{"SPADE_UN_11728": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11728", "Peptide Name": "JH-3 (Derived from  P3)", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "RRFKLLSHSLLVTLASHL", "Sequence Length": 18, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic form", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-", "Antifungal"], "Target Organism": "[Ref.25753638]Gram-positive bacteria :Staphylococcus aureus ATCC29213 (MIC=6.25 μg/ml), Clinical Staphylococcus aureus (MIC=3.125 μg/ml);Gram-negative bacteria :Escherichia coli ATCC25922 (MIC=3.125 μg/ml), Clinical Escherichia coli (MIC=3.125 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=6.25 μg/ml);Fungi :Candida albicans ATCC 90029 (MIC=12.5 μg/ml), Candida albicans Clinical strain (MIC=6.25 μg/ml)", "Hemolytic Activity": "[Ref.25753638] 8% hemolysis at 50 μg/ml , 13% hemolysis at 100 μg/ml , 17% hemolysis at 200 μg/ml , 18% hemolysis at 300 μg/ml , 18.5% hemolysis at 400 μg/ml against human red blood cells", "Cytotoxicity": "[Ref.25753638] The cell viability of HaCaT cell lines is 86% and 86% at peptide concentrations of 200 and 400 μg/ml. In Kunming mice, the LD50 of JH-3 is 180 mg/kg for i.p. injection, , while the LD50 of PMB(served as a control) is 50 mg/kg. No mortali", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C96H163N29O23", "Mass": 2091.5, "PI": 12.0, "Net Charge": 5, "Hydrophobicity": 0.51, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans", "Literature": [{"Title": "Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model", "Pubmed ID": "25753638", "Reference": "Antimicrob Agents Chemother. 2015 May;59(5)2835-41. doi 10.1128/AAC.04932-14.", "Author": "Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=25753638"}], "Frequent Amino Acids": "LSH", "Absent Amino Acids": "CDEGIMNOPQUWY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 11, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_12804", "Similarity": 1.0, "Sequence": "FKLLSHSLLVTLASHLP"}, {"SPADE_ID": "SPADE_UN_20510", "Similarity": 1.0, "Sequence": "FKLLSHSLLVTLASHLP"}, {"SPADE_ID": "SPADE_N_10006", "Similarity": 1.0, "Sequence": "KLLSHSL"}]}}}